Advice
following an abbreviated submission:
colecalciferol tablets (Desunin 800 IU®) is accepted for use within NHS Scotland.
Indication under review: prevention and treatment of vitamin D deficiency in adults and adolescents. In addition to specific osteoporosis treatment of patients who are at risk of vitamin D deficiency, supplemental calcium should be considered.
The therapeutic use and safety profile of colecalciferol as a treatment for vitamin D deficiency and as an adjunctive treatment in osteoporosis is well established. There are no comparative data for colecalciferol (Desunin®). It is the same cost as another vitamin D preparation.
Download detailed advice40KB (PDF)
Medicine details
- Medicine name:
- colecalciferol (Desunin)
- SMC ID:
- 840/13
- Indication:
- For the prevention and treatment of vitamin D deficiency in adults and adolescents.
- Pharmaceutical company
- Meda Pharmaceuticals Ltd
- BNF chapter
- Nutrition and blood
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 11 February 2013